A Multicenter Registry to Evaluate the Long-term Safety and Tolerability of Maintenance Treatment With Iron Sucrose (Venofer) in Pediatric Patients Ages ≥ 2 to ≤ 17 Years With Chronic Kidney Disease
Latest Information Update: 20 Jun 2019
At a glance
- Drugs Iron sucrose (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions
- Sponsors American Regent
- 17 Jun 2019 Status changed from active, no longer recruiting to completed.
- 27 Sep 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Oct 2018.
- 06 Feb 2018 Planned End Date changed from 1 Jan 2018 to 1 Dec 2018.